Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy

Overview of attention for article published in Spine Journal, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs: 1 blog
twitter: 10 X users

patent: 2 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 156 Mendeley

So far, Altmetric has seen 14 X posts from 10 X users, with an upper bound of 13,693 followers.

Even the results of the $MESO trial do not compare...from what i am seeing to the data by $CELZ when it comes to lower back pain https://t.co/pmzJg3ElUJ

RT @doctdeer: Our study on Allogenic Mesenchymal Precursor cells for Chronic Low Back Pain Now on line @ASPN_PainNeuro @ASRA_Society @NAN…

Our study on Allogenic Mesenchymal Precursor cells for Chronic Low Back Pain Now on line @ASPN_PainNeuro @ASRA_Society @NANS_ION #neuromodulation https://t.co/E4eaYslAI4

New2Trip: Allogeneic Mesenchymal Precursor Cells Treatment for Chronic Low Back Pain Associated w/ Degenerative Disc Disease: Prospective Randomized, Placebo-Controlled 36-Month Study of Safety & Efficacy https://t.co/y33IoJhzmV

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.